biotech startups

2 statements across 2 episodes · 2 bullish · 0 bearish · 2 people on the record · first statement Feb 28, 2019 by Koki Hirasaki · across every show →

Everything said about biotech startups, oldest first

Feb 28, 2019 positive
Assertion Not checkable as stated
Biotech Boards Increasingly Retain U.S. Rights and Out-License Ex-U.S. Rights
“What we've seen really over the last 10 years is a lot of boards want the companies to be able to be standalone. And so, what you see are, in this fairly typical and actually Spark is a good example, where the company will keep commercial rights for the U.S. A…”
Koki Hirasaki Feb 28, 2019 ▶ 19:14 What’s with All the Bio M&A in 2019?: A Quick Take
Nov 14, 2025 positive
Assertion Supported
Hershberg: Biotech startups generate two-thirds of newly approved drugs
“Biotech startups now make two thirds of the drugs that go to market.”
Elliot Hershberg Nov 14, 2025 ▶ 15:01 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.